CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Total share-based compensation expense	$ 4,963	$ 6,262	$ 15,567	$ 19,547
Research and development
Total share-based compensation expense	1,111	2,004	3,727	6,301
Selling, general and administrative
Total share-based compensation expense	$ 3,852	$ 4,258	$ 11,840	12,890
Restructuring and related expenses
Total share-based compensation expense				$ 356